Hye-In Jang

Title: Hye-In Jang: Innovator in Pharmaceutical Conjugates

Introduction

Hye-In Jang is a notable inventor based in Seoul, South Korea. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug conjugates. Her work focuses on enhancing the efficacy of therapeutic agents through advanced chemical formulations.

Latest Patents

Hye-In Jang holds a patent for a three-branched polyethylene glycol-G-CSF conjugate. This invention relates to a conjugate of general formula (1), where the bonding ratio of three-branched polyethylene glycol (PEG) and G-CSF is 1:1 (mol/mol). The PEG used in this formulation has an average molecular weight ranging from 200 to 45,000 daltons. The patent also includes a pharmaceutical composition comprising this conjugate and a method for its preparation.

Career Highlights

Throughout her career, Hye-In Jang has worked with prominent companies in the pharmaceutical industry. She has been associated with Dong-A Pharm. Co., Ltd. and Dong-A Socio Holdings Co., Ltd. Her experience in these organizations has contributed to her expertise in drug development and innovation.

Collaborations

Hye-In Jang has collaborated with notable colleagues, including Hyun-Kyu Jeon and Yun-Kyu Choi. These partnerships have facilitated the advancement of her research and the successful implementation of her inventions.

Conclusion

Hye-In Jang is a distinguished inventor whose work in pharmaceutical conjugates has the potential to impact therapeutic applications significantly. Her innovative approach and dedication to research continue to drive advancements in the field.